NXGN News and Press, NextGen Healthcare Inc. From 05/18/22

Gainers: Celularity CELU +10%. Purple Biotech (PPBT) +8%. BioSig Technologies (BSGM) +4%. Concert Pharmaceuticals (CNCE) +4%. Molecular Partners (MOLN) +4%. Losers: Baudax Bio BXRX -28%. Doximity DOCS -9%. Radius Health (RDUS) -7%. N...

NextGen Healthcare, Inc. (NXGN) Q4 2022 Earnings Conference Call May 17, 2022 5:00 PM ET Company Participants Matthew Scalo - Vice President of Investor Relations David Sides - President and Chief Executive Officer James Arnold - Executive Vice President and Chief Financial Officer Conference...

NextGen Healthcare press release (NASDAQ:NXGN): Q4 Non-GAAP EPS of $0.19. Revenue of $151.3M (+4.9% Y/Y). FY 2023 Guidance: Revenue of between $628 million and $640 million Adjusted EBITDA of between $111 million and $116 million Non-GAAP earnings per share of between $0.95 and $1.01 F...

Achieves Record Bookings in the Fiscal 2022 Fourth Quarter NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its operating results for the fiscal fourth quarter and year ended March 31, 202...

Healthcare Technology Report Recognizes 50 Standout Leaders NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that President and Chief Executive Officer David Sides was named a Top 50...

Accomplished Industry Leader Honored by the Orange County Business Journal NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that its Chief Financial Officer, Jamie Arnold, has been hon...

NextGen Healthcare (NASDAQ:NXGN) was upgraded at Guggenheim to Buy from Neutral with a new price target of $26, representing a potential ~32% upside. The firm noted that following NextGen's analyst day and follow-ups with management, it was convinced that the company's growth and ma...

R1 RCM Inc. provides services to increase medical provider reimbursements and is an industry that grows at 10.3% annually. Changing regulations and the need to scale medical care across America will position R1 RCM Inc. to attract larger healthcare providers to its products and servic...

Collaboration Will Enable Patients of Federally Qualified Health Centers to Benefit from Clinical Research, Improve Health Equity for All NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today...

NextGen Healthcare (NASDAQ:NXGN) has reported prelim Q4 GAAP revenue of $150M-$152M, compared to $144.2M in the fourth quarter a year ago and $148.18M consensus. GAAP diluted net income per share is expected to be between $0.00-$0.02, compared to $0.01 net loss per share in the prior year per...